Directorate Appointment

RNS Number : 2817I

Tissue Regenix Group PLC

13 June 2011

 



Tissue Regenix Group plc

Ian Jefferson begins appointment as Chief Financial Officer

YORK, 13 June, 2011 - Tissue Regenix, the regenerative medical device company, today confirms that Ian Jefferson has begun his appointment as Chief Financial Officer (CFO) and has been appointed to the Board of Directors with immediate effect.   Ian's proposed appointment as CFO was announced in March 2011 and he replaces Mike Bretherton, who has become a Non-Executive Director.

ENDS

Enquiries:

Financial Dynamics
Ben Atwell / John Dineen	[phone]
Peel Hunt LLP (Nominated Adviser)
James Steel / Vijay Barathan	[phone]

About Tissue Regenix

Tissue Regenix, the RegenMed Company, was incorporated in May 2006 to commercialise the academic research of Professor Eileen Ingham and Professor John Fisher from the University of Leeds in the field of tissue decellularisation. Its dCELL® Technology comprises a patented process which removes cells and other components from human and animal tissue allowing it to be used without anti-rejection drugs to replace worn out or diseased body parts.

About dCELL®Technology

The process comprised within the dCELL®Technology involves the production of biological scaffolds created by taking a piece of human or animal tissue that is equivalent to the diseased or damaged body part which is being replaced, treating such tissue with a series of gentle chemical washes and then sterilising it. The end product is a scaffold which can be stored under normal conditions at room temperature like any synthetic medical device and, when it is implanted into the body, it repopulates with the patient's own cells using natural biological repair mechanisms.

Tissue Regenix's strategy is to continue to use its core dCELL® Technology as a platform to develop a range of products using the established medical device regulatory pathway to deliver solutions to unmet clinical needs. The three priority markets for the application of the technology are: Vascular (e.g. Vascular Patches); Cardiac (e.g. Heart Valves); and Orthopaedics (e.g. Meniscus).

 

END

 

 

BOASFUFMSFFSEEM